Lipitor, Pravachol Comparison Studies May Cloud OTC Switch Prospects For Statins

Two recently published clinical trials that show a clear and substantial benefit from intensive LDL-cholesterol lowering versus moderate reduction may have a chilling effect on efforts to switch statins OTC in the U.S.